Equipoise 300 - Canada Peptides

Marketed as Equipoise, Boldenone Undecylenate was synthesized for veterinary purposes and gained FDA approval only for animal use. It was not released for clinical human therapy. It became popular in bodybuilding for its steady anabolic action and minimal water retention. Though relatively mild, it still suppresses natural testosterone, making PCT necessary. Developed as a long-acting injectable, its slow-release design offered an appealing alternative to short-acting anabolic esters.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Equipoise 300 by Canada Peptides, consult with your doctor or healthcare professional.